were recruited. Information, including demographic data, presenting symptoms and vital signs at presentation, predisposing factors for PE, results of diagnostic procedures and clinical outcomes, was collected from the medical records of these patients. CONClUSION Elevated cTnI level was associated with a complicated clinical course in patients with acute PE. We suggest that measurements of cTnI levels be used for the early risk stratification of patients with PE in the emergency departments of hospitals.
INTRODUCTION
Venous thromboembolism (VTE) is a spectrum of diseases that includes deep vein thrombosis (DVT) and pulmonary embolism (PE). PE is a potentially fatal complication of DVT. Despite recent advances in the diagnosis and treatment of PE, the risk stratification of cardiopulmonary mortality in patients with PE remains difficult. Haemodynamic instability is associated with in-hospital mortality, which can be as high as 50% in patients with PE.
(1) Among patients having acute PE with normal blood pressure at presentation, acute right ventricular (RV) failure is a poor prognostic factor. (1) RV failure can be demonstrated by echocardiography, which shows RV enlargement and hypokinesis. (2) However, this test is not always available in the emergency departments of hospitals, and it also depends heavily on the experience and capability of the operators. Plasma cardiac troponin I (cTnI) is a highly sensitive and specific biochemical marker for myocardial injury. (3) Elevated cTnI levels are observed in patients with acute PE, especially in those with massive PE.
In addition, TnI level has prognostic implications, as it reflects myocardial injury and RV dysfunction. (4) (5) (6) VTE is common in Caucasians, with an annual estimated incidence of 117 cases per 100,000 persons in the United States.
It is less common among Asians, including persons of Chinese ancestry. A local study has found that the annual incidence of VTE among Hong Kong Chinese patients was 16.6 per 100,000
population. (8) One possible explanation for the lower incidence of VTE seen among Chinese patients may be related to the prevalence of activated protein C resistance, which is extremely low in Chinese populations. (9) However, evidence of the prognostic value of cTnI in Chinese patients with PE is scarce. Therefore, this retrospective study was conducted to assess whether cTnI levels could predict clinical outcomes and complications in
Chinese patients with PE.
METHODS
This was a retrospective study carried out between January A p-value < 0.05 was considered to be statistically significant.
RESUlTS
During the study period, 110 Chinese patients were admitted for acute PE. Of these, 10 (9.1%) patients were excluded from the study due to unavailability of cTnI investigations. Of the 100 (90.9%) patients that were finally recruited in the study, 48
(48.0%) were men. The median age of the patients at diagnosis was 68.5 (IQR 48.0-81.0) years. The diagnosis of PE was confirmed using contrast CT imaging in 98 (98.0%) patients and by high-probability lung scintigraphy in 2 (2.0%) patients. Doppler ultrasonography of the lower limbs was performed in 73 (73.0%) patients, and among these, 40 (54.8%) patients were diagnosed to have concurrent DVT.
The baseline characteristics of patients are summarised in Table I . There was no significant difference in the baseline (Table II) .
On univariate analysis, elevated cTnI levels were associated with haemodynamic instability (Table III) . Subsequent multivariate logistic regression analysis showed that the risk of developing haemodynamic instability was independently associated with elevated cTnI levels, independent of age and malignancy. The OR of elevated cTnI was 5.3 (95% CI 1.3-27.7; p = 0.019). 15 (15.0%) patients died during the hospitalisation period. Haemodynamic instability at presentation and malignancy were associated with in-hospital mortality on univariate analysis (Table IV) . However, cTnI levels failed to demonstrate a statistically significant association with in-hospital mortality on univariate analysis. After adjusting for potential confounders, including haemodynamic instability at presentation and malignancy, it was found that elevated cTnI might be weakly associated with higher in-hospital mortality (OR 5.1, 95% CI 0.9-28.4; p = 0.066).
DISCUSSION
According to Goldhaber, hypotension and RV overload, which can be assessed by echocardiography, can be used to stratify patients with acute PE for the risk of death. (13) However, 24-hour echocardiography by experienced personnel is a prerequisite for accurate diagnosis, and disagreement exists regarding the criteria for RV dysfunction. Other studies have shown that cTnI is a highly sensitive marker for RV dysfunction and suggested that elevated cTnI levels are associated with mortality and adverse clinical outcome. (14) (15) (16) The findings of our study are consistent with these earlier reports.
In the present study, cTnI was found to predict complicated clinical course and haemodynamic instability in Chinese patients with acute PE. Its prognostic value was also observed in patients who were haemodynamically stable at presentation. However, this study failed to demonstrate a statistically significant relationship between elevated cTnI levels and in-hospital mortality (p = 0.066).
In our study, the time lapse between the onset of symptoms of first acute PE episode and presentation at the hospital was markedly shorter in patients with elevated cTnI (24 hours vs. 48
hours, p = 0.01). Punukollu et al, who found that no patient with a duration of symptoms > 72 hours would have raised cTnI in spite of the presence of RV dysfunction, concluded that the dynamics of cTnI release are different between patients with duration of symptoms > 72 hours and those with a shorter duration of symptoms. (17) Therefore, it is possible that a patient with acute PE who presents late to a hospital may have a normal cTnI level on admission even though RV dysfunction is present. In our study, the duration of symptoms was longer than 72 hours for 17 (17.0%) patients who presented with PE. Clinicians should bear in mind that cTnI might not predict the prognosis for these patients.
Our study also revealed that the negative predictive value of cTnI for complicated clinical course was high (89.7%). This finding is consistent with those by Konstantinides et al (6) and Kucher et al, (4) who reported slightly higher negative predictive values of 93% and 95%, respectively. Recent studies have shown that repeat cTnI measurement has additional prognostic value.
According to Pruszczyk et al (18) and Müller-Bardorff et al, (19) patients with acute PE may have normal cTnI levels at presentation, but show elevated cTnI later at 6 and 12 hours. We suggest that cTnI measurement be performed for all patients presenting with acute PE whose duration of symptoms is less than 72 hours.
cTnI measurements should be repeated at 6 and 12 hours for such patients, if the initial cTnI readings are normal. In our study, elevated cTnI levels were associated with complicated clinical course in patients with PE, and therefore, prompt thrombolytic therapy and intensive care are warranted for these patients.
Our study, however, was not without limitations. As this was a retrospective study, it was thus subject to selection bias and recall bias. Investigations of the association between raised cTnI and RV dysfunction were limited, as only 53% of our patients had undergone echocardiography. Our modest sample size also limited the power of the study with regard to in-hospital mortality.
Furthermore, it was difficult to exclude concomitant acute coronary syndromes in patients who had raised cTnI but no acute ischaemic changes on ECG. Finally, patients with very massive PE who died in the emergency department on or before arrival, for whom autopsy was not performed, were excluded from the study.
In conclusion, we found that elevated cTnI levels were predictive for a subgroup of patients with acute PE who were prone to develop haemodynamic instability and complications in the clinical course during hospitalisation. We propose that cTnI be used as a marker for the early risk stratification of patients presenting with acute PE to the emergency departments of hospitals.
